Antibody blockade of CD96 by distinct molecular mechanisms
The molecular interactions of mouse CD96 to CD155 ligand and to two surrogate antibodies have been investigated. Biophysical and structural studies demonstrate that CD96 forms a homodimer but assembles as 1:1 heterodimeric complexes with CD155 or with one of the surrogate antibodies, which compete f...
Saved in:
Main Authors: | Peter S. Lee (Author), Bryant Chau (Author), Ishita Barman (Author), Christine Bee (Author), Aarti Jashnani (Author), Jason M. Hogan (Author), Barbara Aguilar (Author), Gavin Dollinger (Author), Arvind Rajpal (Author), Pavel Strop (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biophysical characterization of PVR family interactions and therapeutic antibody recognition to TIGIT
by: SJ J. Diong, et al.
Published: (2023) -
Improved therapeutic index of an acidic pH-selective antibody
by: Peter S. Lee, et al.
Published: (2022) -
Design and characterization of mouse IgG1 and IgG2a bispecific antibodies for use in syngeneic models
by: Feng Wang, et al.
Published: (2020) -
Overcoming immunotherapeutic resistance in PDAC: SIRPα-CD47 blockade
by: Abdullahi Alausa, et al.
Published: (2022) -
Checkpoint inhibitor blockade and epigenetic reprogrammability in CD8 T-cell activation and exhaustion
by: José Belizário, et al.
Published: (2020)